Schizophrenia (精神分裂症) is a mental disease compromised by a devastating
array of psychotic, emotional and cognitive symptoms. For those of
you who do not know much about Schizophrenia, go to Blockbuster video
and rent the movie "A beautiful mind". While psychiatric diagnosis
and limited treatments are available, the biological basis for
Schizophrenia is virtually unknown, up until now. While
Schizophrenia has been thought to be a brain disease, neuroscience
research on Schizophrenia has been very slow in making progress (You
can not blame this on scientists - We use mice and rats to study brain
functions and disorders and how can we tell is a mouse or rat is
schizophrenic - Schizophrenia is thought to be a human-unique
disorder). In the May issue of NEURON, two papers provide evidence
that link neuregulin-ErbB signaling in synaptic activity in to
Schizophrenia. For a brief summary of these findings, please read the
news & view on Nature by Lorna Role and David A. Talmage (the pdf file
is provided in this group).
1. Li, B., Woo, R.-S., Mei, L. & Malinow, R. The Neuregulin-1 Receptor
ErbB4 Controls Glutamatergic Synapse Maturation and Plasticity.
Neuron 54, 583–597(2007).
2. Woo, R.-S. et al. Neuregulin-1 Enhances Depolarization-Induced GABA
Release. Neuron 54, 599–610 (2007).